Switching treatments in COPD: implications for costs and treatment adherence

References

• Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)2014 Available from: http://www.goldcopd.orgAccessed November 16, 2014
   Google Scholar
• BrocklebankDRamFWrightJComparison of the effectiveness of inhaler devices in asthma and chronic obstructive airway disease; a systematic review of the literatureHealth Technol Assess2001526114911701099
   PubMedGoogle Scholar
• DolovichMBAhrensRCHessDRDevice selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and ImmunologyChest2005127133537115654001
   PubMed Web of Science ®Google Scholar
• BerlinskiAAssessing new technologies in aerosol medicine: strengths and limitationsRespir Care201560683384926070578
   PubMed Web of Science ®Google Scholar
• LaubeBLJanssensHMDe JonghFHWhat the pulmonary specialist should know about the new inhalation therapiesEur Respir J20113761308133121310878
   PubMed Web of Science ®Google Scholar
• CromptonGKBarnesPJBroedersMThe need to improve inhalation technique in Europe: a report by the aerosol drug management improvement teamRespir Med200610091479149416495040
   PubMed Web of Science ®Google Scholar
• TashkinDPMultiple dose regimens: impact on complianceChest19951075176S182S7743823
   PubMed Web of Science ®Google Scholar
• TamuraGOhtaKAdherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patchRespir Med200710191895190217587559
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax2009641193994319703830
   PubMed Web of Science ®Google Scholar
• CarlsGSRoebuckMCBrennanTASlezakJAMatlinOSGibsonTBImpact of medication adherence on absenteeism and short-term disability for five chronic diseasesJ Occup Environ Med201254779280522796923
   PubMed Web of Science ®Google Scholar
• LavoriniFMagnanADubusJCEffect of incorrect use of dry powder inhalers on management of patients with asthma and COPDRespir Med2008102459360418083019
   PubMed Web of Science ®Google Scholar
• Penning-van BeestFvan Herk-SukelMGaleRLammersJWHeringsRThree-year dispensing patterns with long-acting inhaled drugs in COPD: a database analysisRespir Med2011105225926620705441
   PubMed Web of Science ®Google Scholar
• RossiAvan der MolenTdel OlmoRINSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPDEur Respir J20144461548155525359348
   PubMed Web of Science ®Google Scholar
• HanadaSWadaSOhnoTSawaguchiHMurakiMTohdaYQuestionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchInt J Chron Obstruct Pulmon Dis2015610697725609941
   PubMed Web of Science ®Google Scholar
• YuAPGuérinAPonce de LeonDTherapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalersJ Med Econ201114448649621679019
   PubMedGoogle Scholar
• Daley-YatesPParkinsDEstablishing bioequivalence for inhaled drugs; weighing the evidenceExp Opin Drug Deliv201181112971308
   Web of Science ®Google Scholar
• European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP)Guideline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary diseaseCHMPCfMPfHULondon2009
   Google Scholar
• Guidance for industry: Guidance for the in vitro portion of bioequivalence requirements for metaproterenol sulfate and albuterol inhalation aerosols (metered dose inhalers) Center for Drug Evaluation and ResearchUS Department of Health and Human ServicesFood and Drug Administration1989 Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070242.pdfAccessed August 3, 2015
   Google Scholar
• US Food and Drug AdministrationUS FDA. Drug-development approval process Scientific and Regulatory Considerations for Bioequivalence (BE) of Dry Powder Inhalers (DPIs)Silver Spring, MDUS Food and Drug Administration2011
   Google Scholar
• La Banca Dati Farmaci [The drugs database]Agenzia Italiana del Farmaco (AIFA) Available from: https://farmaci.agenziafarmaco.gov.it/Accessed November 16, 2014 Italian
   Google Scholar
• GINA Report, Global Strategy for Asthma Management and Prevention [updated December 2011]. Available from: http://www.ginasthma.org
   Google Scholar
• LavoriniFNinaneVHaughneyJBjermerLMolimardMDekhuijzenRPSwitching from branded to generic inhaled medications: potential impact on asthma and COPDExpert Opin Drug Deliv201310121597160224224777
   PubMed Web of Science ®Google Scholar
• DoyleSLloydAWilliamsAWhat happens to patients who have their asthma device switched without their consent?Prim Care Respir J201019213113920174771
   PubMedGoogle Scholar
• ThomasMPriceDChrystynHInhaled corticosteroids for asthma: impact of practice level device switching on asthma controlBMC Pulm Med20099119121204
   PubMedGoogle Scholar
• van BovenJFTommeleinEBousseryKImproving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysisRespir Res2014156624929799
   PubMed Web of Science ®Google Scholar
• ChrystynHDo patients show the same level of adherence with all dry powder inhalers?Int J Clin Pract Suppl2005149192516279999
   PubMedGoogle Scholar
• SchulteMOsseiranKBetzRHandling of and preferences for available dry powder inhaler systems by patients with asthma and COPDJ Aerosol Med Pulm Drug Deliv200821432132818823257
   PubMed Web of Science ®Google Scholar
• SmallMAndersonPVickersAKaySFermerSImportance of inhaler-device satisfaction in asthma treatment: real-world observations of physician-observed compliance and clinical/patient-reported outcomesAdv Ther201128320221221331556
   PubMed Web of Science ®Google Scholar
• AzouzWChrystynHClarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practicePrim Care Respir J2012152120821322336894
   PubMedGoogle Scholar
• MolimardMRaherisonCLignotSDepontFAbouelfathAMooreNAssessment of handling of inhaler devices in real life: an observational study in 3,811 patients in primary careJ Aerosol Med200316324925414572322
   PubMedGoogle Scholar
• PriceDDo healthcare professionals think that dry powder inhalers can be used interchangeably?Int J Clin Pract Suppl2005149262916280000
   PubMedGoogle Scholar
• BuchananAPinnockHBarnesJHawksworthGWellerTLynesDGeneric prescribing of breath actuated and dry powder inhalers in the UKPrim Care Respir J200211395
   Google Scholar
• TommeleinEMehuysEVan HeesTEffectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trialBr J Clin Pharmacol201477575676624117908
   PubMed Web of Science ®Google Scholar
• BraidoFBaiardiniIBlasiFPawankarRCanonicaGWAdherence to asthma treatments: ‘we know, we intend, we advocate’Curr Opin Allergy Clin Immunol2015151495525479318
   PubMed Web of Science ®Google Scholar
• LavoriniFBraidoFBaiardiniIBlasiFCanonicaGWSIAAC-SIMERAsthma and COPD: interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR)Pulm Pharmacol Ther Epub2015722
   Web of Science ®Google Scholar
• WilliamsAChrystynHSurvey of pharmacists’ attitude towards interchangeable use of dry powder inhalerPharm World Sci200729322122717242855
   PubMed Web of Science ®Google Scholar